Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy von Dobrzanski, Mark J

Volltext

Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate “Natural” and “Inducible” CD4 TReg cell subpopulation levels: observations in four cases of patients with... von Dobrzanski, Mark J., Rewers-Felkins, Kathleen A., Samad, Khaliquzzaman A., Quinlin, Imelda S., Phillips, Catherine A., Robinson, William, Dobrzanski, David J., Wright, Stephen E.

Volltext

Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer von Reome, Joyce B, Hylind, James C, Dutton, Richard W, Dobrzanski, Mark J

Volltext

Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival von Dobrzanski, Mark J, Rewers-Felkins, Kathleen A, Quinlin, Imelda S, Samad, Khaliquzzaman A, Phillips, Catherine A, Robinson, William, Dobrzanski, David J, Wright, Stephen E

Volltext

Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer: A Pilot Study von WRIGHT, Stephen E, REWERS-FELKINS, Kathleen A, QUINLIN, Imelda S, PHILLIPS, Catherine A, TOWNSEND, Mary, PHILIP, Ramila, DOBRZANSKI, Mark J, LOCKWOOD-COOKE, Pamela R, ROBINSON, William

Volltext

CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Can... von Dobrzanski, Mark J, Reome, Joyce B, Hylind, James C, Rewers-Felkins, Kathleen A

Volltext

Tc1 and Tc2 Effector Cell Therapy Elicit Long-Term Tumor Immunity by Contrasting Mechanisms That Result in Complementary Endogenous Type 1 Antitumor Responses von Dobrzanski, Mark J, Reome, Joyce B, Hollenbaugh, Joseph A, Dutton, Richard W

Volltext

Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases von Dobrzanski, Mark J, Reome, Joyce B, Dutton, Richard W

Volltext

Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor von Dobrzanski, Mark J, Reome, Joyce B, Dutton, Richard W

Volltext

Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in est... von Dobrzanski, Mark J, Reome, Joyce B, Hylind, James C, Rewers-Felkins, Kathleen A, Abulsamad, Khaliquzzaman, Adams, Shawna L

Volltext

Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection von Dobrzanski, Mark J, Reome, Joyce B, Dutton, Richard W

Volltext

Effector cell-derived lymphotoxin alpha and Fas ligand, but not perforin, promote Tc1 and Tc2 effector cell-mediated tumor therapy in established pulmonary metastases von Dobrzanski, Mark J, Reome, Joyce B, Hollenbaugh, Joseph A, Hylind, James C, Dutton, Richard W

Volltext

Immunopotentiating Role of IFN-γ in Early and Late Stages of Type 1 CD8 Effector Cell-Mediated Tumor Rejection von Dobrzanski, Mark J., Reome, Joyce B., Dutton, Richard W.

Volltext

Ag-Specific Type 1 CD8 Effector Cells Enhance Methotrexate-Mediated Antitumor Responses by Modulating Endogenous CD49b-Expressing CD4 and CD8 T Effector Cell Subpopulations Produci... von Dobrzanski, Mark J., Reome, Joyce B., Hylind, James C., Rewers-Felkins, Kathleen A., Abdulsamad, Khaliquzzaman, Adams, Shawna L.

Volltext

Immunotherapy with IL-10- and IFN-[gamma]-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients... von Dobrzanski, Mark J, Rewers-felkins, Kathleen A, Samad, Khaliquzzaman A, Quinlin, Imelda S, Phillips, Catherine A, Robinson, William, Dobrzanski, David J, Wright, Stephen E

Volltext

Differential expression of CD4+ TReg cell subpopulations among ovarian cancer patients following autologous MUC1-specific Th1 effector cell immunotherapy (41.38) von Dobrzanski, Mark J, Rewers-Felkins, Kathleen, Samad, K.A., Robinson, William, Wright, Stephen E

Volltext

Autologous MUC1-Specific Th1 Effector Cell Immunotherapy Induce Differential Levels of Systemic TReg Cell Subpopulations That Result in Increased Ovarian Cancer Patient Survival von Dobrzanski, Mark J., Rewers-Felkins, Kathleen A., Quinlin, Imelda S., Samad, Khaliquzzaman A., Phillips, Catherine A., Robinson, William, Dobrzanski, David J., Wright, Stephen E.

Volltext

Autologous MUC1-specific Th 1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival von DOBRZANSKI, Mark J, REWERS-FELKINS, Kathleen A, QUINLIN, Imelda S, SAMAD, Khaliquzzaman A, PHILLIPS, Catherine A, ROBINSON, William, DOBRZANSKI, David J, WRIGHT, Stephen E

Volltext

Effector cell-derived lymphotoxin a and Fas ligand, but not perforin, promote Tcl and Tc2 effector cell-mediated tumor therapy in established pulmonary metastases von DOBRZANSKI, Mark J, REOME, Joyce B, HOLLENBAUGH, Joseph A, HYLIND, James C, DUTTON, Richard W

Volltext

Peptide‐specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K‐ras p21 von Abrams, Scott I., Dobrzanski, Mark J., Wells, Donald T., Stanziale, Stephen F., Zaremba, Sam, Masuelle, Laura, Kantor, Judith A., Schlom, Jeffrey

Volltext